VO2 Max: In Vivo Model for Functional Red Cell Testing. Can RECESS be Explained?

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-31

Study Completion Date

2019-11-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a single-center, randomized, partially blinded study to determine whether 42-day old red blood cells (RBCs) deliver oxygen as effectively as 7-day old RBCs and also to determine whether transfusion with 28-day old RBCs is non-inferior to 7-day old RBCs with respect to oxygen delivery.

In this study, subjects will be randomized to be transfused with 2 units of autologous (one's own) RBCs that are either 7-, 28-, or 42-days old. Endpoints include changes in exercise duration and VO2 max (test of oxygen consumption/delivery) between groups.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

An In Vivo 24-Hour Recovery Study of Whole Blood by the Reveos System

NCT05239455

Device Validation of In-vivo Performance

COMPLETED NA

Trima Non-DEHP Leukoreduced Red Blood Cell In Vivo Recovery Study

NCT06602804

Device Validation of In-vivo Performance

COMPLETED NA

Non-Invasive Hemoglobin Study

NCT02206399

Anemia

COMPLETED

A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1

NCT07015437

Healthy Subjects

RECRUITING PHASE2

Recovery and Lifespan of Red Blood Cells From Pathogen-reduced, Stored Blood Units

NCT03384407

Red Cell Survival in Healthy Volunteers

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The US Food and Drug Administration (FDA) regulations permit additive-containing RBCs to be stored for up to 42 days prior to transfusion. However, RBCs progressively develop abnormalities during storage. The efficacy of older stored blood, i.e., effective oxygen delivery, has not been established in rigorous controlled studies. Due to pragmatic reasons, a large clinical trial that randomizes patients to "old" blood may not be feasible.

Every subject will have 2 phlebotomy visits at Stony Brook University Hospital. Subjects randomized to the 7- and 42-day old groups will have 2 units of blood removed at Week 0 and another 2 units removed at Week 5. However, the remaining 28-day group will have 2 units of blood removed at Week 2 and only 1 unit of blood removed at Week 5. During week 6, each subjects will have 3 study visits: 1) On Monday, a VO2 max test; 2) On Wednesday, a transfusion with 2 units of autologous RBCs (each over 1 hour), followed by a VO2 max test 2 hours later; 3) On Friday, a VO2 max test will be done in order to calculate a delta VO2 max (Friday minus Monday results).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

7-day old RBCs

Transfusion of 7-day stored red blood cells: Subjects will be transfused with their own 7-day old red blood cells

Group Type EXPERIMENTAL

Transfusion of 7-day stored red blood cells

Intervention Type BIOLOGICAL

Subjects will donate blood at Week 0 and Week 5 of their participation and receive, at Week 6, back a transfusion of their Week 5 (7-day old) red blood cells.

28-day old RBCs

Transfusion of 28-day stored red blood cells: Subjects will be transfused with their own 28-day old red blood cells

Group Type EXPERIMENTAL

Transfusion of 28-day stored red blood cells

Intervention Type BIOLOGICAL

Subjects will donate blood at Week 2 and Week 5 of their participation and receive, at Week 6, back a transfusion of their Week 2 (28-day old) red blood cells.

42-day old RBCs

Transfusion of 42-day stored red blood cells: Subjects will be transfused with their own 42-day old red blood cells

Group Type EXPERIMENTAL

Transfusion of 42-day stored red blood cells

Intervention Type BIOLOGICAL

Subjects will donate blood at Week 0 and Week 5 of their participation and receive, at Week 6, back a transfusion of their Week0 (42-day old) red blood cells.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transfusion of 7-day stored red blood cells

Subjects will donate blood at Week 0 and Week 5 of their participation and receive, at Week 6, back a transfusion of their Week 5 (7-day old) red blood cells.

Intervention Type BIOLOGICAL

Transfusion of 28-day stored red blood cells

Subjects will donate blood at Week 2 and Week 5 of their participation and receive, at Week 6, back a transfusion of their Week 2 (28-day old) red blood cells.

Intervention Type BIOLOGICAL

Transfusion of 42-day stored red blood cells

Subjects will donate blood at Week 0 and Week 5 of their participation and receive, at Week 6, back a transfusion of their Week0 (42-day old) red blood cells.

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Habitual exerciser defined as ≥ 30 minutes of at least moderate or high intensity exercise ≥ 3 times per week. After consent, and at the subsequent screening visit, a VO2 max test will be performed, and subjects with a low value (\< 35 mL/kg/min) will be excluded (screen failure). Based on our previous experience, we anticipate that \<10% of the subjects will fall into this category
* Calculated total blood volume (TBV) ≥4,500 mL using an established formula:

1. Men: (0.006012 x H3) + (14.6 x W) + 604 = TBV
2. Women: (0.005835 x H3) + (15 x W) + 183 = TBV \[H=height in inches; W=weight in pounds\]
* Has access to transportation to visit the blood collection facility and to return to Stony Brook for all study visits.

Exclusion Criteria

* Any significant acute or chronic medical illness or problem, including, but not limited to, diabetes, hypertension, cardiac disease, asthma, chronic obstructive lung disease
* Current or recent (last 60 days) tobacco or nicotine use
* History of sickle cell trait or disease or any other acquired or hereditary hematological abnormality
* History of fainting or other significant adverse reaction during phlebotomy or donation of blood
* Known prolonged corrected QT interval (or evidence of such at screening) on electrocardiogram defined as \>470 ms
* Known or suspected illicit drug or alcohol abuse
* Known or suspected HIV, Hepatitis B, or Hepatitis C infection
* History of thrombophilia or anticoagulant therapy
* Pregnancy
* Obesity defined as BMI\>30
* Recent history of blood donation: a) Single whole blood unit donation within the past 8 weeks; b) Double RBC donation by apheresis within the past 16 weeks; or c) Plasma donation by apheresis within the past 4 weeks
* Inadequate RBC mass based on TBV \<4500 ml (above) or screening Hb \<14 g/dL

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes